Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Risk of Neoplasia in Pediatric Patients Receiving Growth Hormone Therapy--A Report From the Pediatric Endocrine Society Drug and Therapeutics Committee.

The Journal of clinical endocrinology and metabolism - 1 Jun 2015

Raman Sripriya, Grimberg Adda, Waguespack Steven G, Miller Bradley S, Sklar Charles A, Meacham Lillian R, Patterson Briana C

Abstract excerpt

CONTEXT: GH and IGF-1 have been shown to affect tumor growth in vitro and in some animal models. This report summarizes the available evidence on whether GH therapy in childhood is associated with an increased risk of neoplasia during treatment or after treatment is completed. EVIDENCE ACQUISITIO...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Child
Share to Growth Disorders
Share to Hormone Replacement Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Human Growth Hormone

Share to Neoplasms

Share to Risk Factors

Share to Survivors

Share to Syndrome

Source

Open in PubMed Open full text

Identifiers

PMID: 25839904
DOI: 10.1210/jc.2015-1002
PMCID: PMC5393518

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-25839904-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Risk of Neoplasia in Pediatric Patients Receiving Growth Hormone Therapy--A Report From the Pediatric Endocrine Society Drug and Therapeutics Committee.PMID 25839904Read ↗

Risk of cancer in patients treated with recombinant human growth hormone in childhoodSemantic proximity Read ↗

Growth hormone and cancerSemantic proximity Read ↗

The role of IGF-1R in pediatric malignancies.Semantic proximity Read ↗

Involvement of the IGF system in fetal growth and childhood cancer: an overview of potential mechanismsSemantic proximity Read ↗

Update in growth hormone therapy of children.Semantic proximity Read ↗

Design of the long-term observational cohort study with recombinant human growth hormone in Korean children: LG Growth StudySemantic proximity Read ↗

Growth hormone, IGF-I and cancer. Less intervention to avoid cancer? More intervention to prevent cancer?Semantic proximity Read ↗

GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adultsSemantic proximity Read ↗

The Effects of Insulin-Like Growth Factors on Tumorigenesis and Neoplastic GrowthSemantic proximity Read ↗

Long-term endocrine sequelae after hematopoietic stem cell transplantation in children and adolescentsSemantic proximity Read ↗

Congenital IGF1 deficiency tends to confer protection against post-natal development of malignanciesSemantic proximity Read ↗

Intrauterine growth and childhood leukemia and lymphoma risk.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.